CAS 220651-94-5

Ruplizumab

CAS: 220651-94-5

PF-03732010 is a humanized antibody targeting P-calmodulin with antitumor and antimetastatic activity.

Reinheit: 98.5% (SDS-PAGE); 98.7% (SEC-HPLC) - 98.5% (SDS-PAGE); 98.7% (SEC-HPLC)

Farbe und Form: Liquid

Molekulargewicht: 145.42 kDa

Ref: TM-T76825

Ruplizumab

CAS: 220651-94-5

Humanized whole monoclonal antibody targeting CD154; designed to treat rheumatic diseases

Ref: 3D-CLA1059